KPV and inflammatory signals
The most useful complication is a response that changed in one experiment and stayed put in another.
Human keratinocyte signalling
A paper on human keratinocyte cells examined alpha-MSH, its KPV fragment and adrenocorticotropic hormone. In these skin-relevant cell systems, KPV reproduced anti-inflammatory signalling of the full alpha-MSH peptide. The cutaneous setting earns my interest: this question concerns skin-relevant cells directly.
The family connection is real. Drawing on cell and animal research, a review of alpha-MSH and related tripeptides describes KPV as the C-terminal fragment, the short sequence at the end, that retains anti-inflammatory activity while lacking the full hormone’s pigmentary action. I’m less absorbed by that family history than by the response of a cell under stress. The fine-dust experiment gives that interest a particular environmental challenge.

The macrophage result
The fragment-dissection study gives the broad family resemblance a useful complication. In mice with crystal-induced peritonitis, KPV reduced accumulation of polymorphonuclear leukocytes. In cultured macrophages, KPV did not suppress cytokine release as the core alpha-MSH peptides did. Cytokines are signalling proteins; in this experiment, their release was a separate outcome from cells accumulating at an inflamed site.
I’d granted the family resemblance too much explanatory power. This result spoiled that tidiness in a productive way. The authors considered an action directed towards interleukin-1 beta function more likely than an action through melanocortin receptors. That remains a proposed explanation in this experiment.
A mouse abdominal-inflammation model and cultured macrophages are a different setting from human keratinocytes. I cannot call their differences a failed replication of the skin experiment. What they do offer is a warning against making one mechanism cover every tissue and experimental challenge.
Comparing the experimental questions
The keratinocyte signalling paper concerns a response in skin-relevant cells. The fine-dust study adds a specified environmental insult and reports changes in inflammation and apoptosis. The fragment-dissection experiment separates outcomes across a mouse model and macrophage cultures.
I trust that collection of specific questions more than the phrase “calms inflammation” on its own. It leaves the differences visible. There is no reason to expect the face to look different merely because the explanation sounds complete. For a change in an injured surface itself, the rabbit corneal experiment offers a different kind of endpoint.